date,title,source
Oct-17-18,Stocks Jump 2%+ on Solid Earnings,Zacks
Oct-19-18,Phase 2 GEOMETRY mono-1 Trial of Investigational Medicine Capmatinib Shows Positive Results in Patients with MET-mutated Advanced NSCLC,Business Wire
Oct-24-18,Incyte (INCY) to Report Q3 Earnings: What's in the Cards?,Zacks
Oct-24-18,"Biotech Stock Roundup: BIIB Tops, MACK Plunges, REGN's Asthma Drug Gets FDA Nod",Zacks
Oct-25-18,Incyte Named a 2018 Top Employer by Science Magazine,Business Wire
Oct-30-18,Incyte Corp (INCY) Q3 2018 Earnings Conference Call Transcript,Motley Fool
Oct-30-18,"Incyte (INCY) Misses on Q3 Earnings & Revenues, Updates View",Zacks
Oct-30-18,Edited Transcript of INCY earnings conference call or presentation 30-Oct-18 12:00pm GMT,Thomson Reuters StreetEvents
Oct-30-18,Incyte (INCY) Misses Q3 Earnings and Revenue Estimates,Zacks
Oct-30-18,Incyte: 3Q Earnings Snapshot,Associated Press
Oct-30-18,Incyte Reports 2018 Third Quarter and Nine Month Financial Results and Provides Updates on Key Clinical Programs,Business Wire
Oct-31-18,Edited Transcript of INCY earnings conference call or presentation 30-Oct-18 12:00pm GMT,Thomson Reuters StreetEvents
Nov-01-18,"Scary Markets, Frightening Stocks, and How to Keep From Panicking",Motley Fool
Nov-01-18,Edited Transcript of INCY earnings conference call or presentation 30-Oct-18 12:00pm GMT,Thomson Reuters StreetEvents
Nov-01-18,Multiple Abstracts Highlighting Data from Incytes Targeted Therapy Portfolio Accepted for Presentation at the 60th Annual ASH Meeting,Business Wire
Nov-01-18,"3 Big Stock Charts for Thursday: Walmart, Prologis and Incyte",InvestorPlace
Nov-01-18,Today's Research Reports on Trending Tickers: Agios Pharmaceuticals and Incyte,ACCESSWIRE
Nov-05-18,"Factors of Influence in 2018, Key Indicators and Opportunity within Molson Coors Brewing, Coca-Cola European Partners, Brinker International, Incyte, RPC, and Group 1 Automotive  New Research Emphasizes Economic Growth",GlobeNewswire
Nov-07-18,Incyte to Present at Upcoming Investor Conference,Business Wire
Nov-15-18,Merck's Keytruda Improves Survival in Esophageal Cancer Study,Zacks
Nov-19-18,"AstraZeneca's Imfinzi Fails in Lung Cancer Study, Stock Down",Zacks
Nov-21-18,This Highly Rated Pharma Giant Is More Than Just A Diabetes Player,Investor's Business Daily
Nov-23-18,A Look At The Intrinsic Value Of Incyte Corporation (NASDAQ:INCY),Simply Wall St.
Nov-27-18,Incyte Appoints Dr. Dashyant Dhanak as Chief Scientific Officer,Business Wire
Nov-29-18,Why Is Incyte (INCY) Up 1.5% Since Last Earnings Report?,Zacks
Dec-04-18,Incyte (INCY) Announces Positive Data on Jakafi for GVHD,Zacks
Dec-04-18,Today's Research Reports on Trending Tickers: Incyte and Supernus Pharmaceuticals,ACCESSWIRE
Dec-06-18,"Shire (SHPG), Takeda Shareholders Approve $62 Billion Merger",Zacks
Dec-10-18,Why MacroGenics Stock Is Getting Hammered Today,Motley Fool
Dec-10-18,5 Top Drug/Biotech Merger & Acquisition Targets for 2019,Zacks
Dec-12-18,Roche to Create Companion Diagnostic Test for Merck's Keytruda,Zacks
Dec-13-18,Top 10 Healthcare Stories of 2018,Motley Fool
Dec-13-18,Incyte to Present at Upcoming Investor Conferences,Business Wire
Dec-13-18,FDA Grants Fast Track Designation to the Baricitinib Development Program for the Treatment of Systemic Lupus Erythematosus (SLE),PR Newswire
Dec-14-18,5 Biotech Stocks Set to Bounce Back in '19 After a Rough Ride,Zacks
Dec-17-18,Incyte (INCY) Collaborates with Innovent for 3 Candidates,Zacks
Dec-17-18,Incyte enters into potential $391M collaboration with Chinese biopharm firm,American City Business Journals
Dec-18-18,Here Are Biotechs Big Pipeline Disappointments in 2018,Motley Fool
Dec-18-18,Immuno-Oncology Suffered a Setback in 2018. Whats Next?,Motley Fool
Dec-19-18,"Biotech Stock Roundup: Pipeline Updates From VRTX & AMGN, ADRO Teams Up With LLY",Zacks
Dec-20-18,Incyte Announces First Patient Treated in Phase 3 Clinical Trial Program for Ruxolitinib Cream in Atopic Dermatitis,Business Wire
Dec-20-18,"The Zacks Analyst Blog Highlights: Amgen, Aduro, Vertex, Evofem and Incyte",Zacks
Dec-21-18,Merck's sBLA for Keytruda in Lung Cancer Gets Extended Review,Zacks
